Validation of [(18)F]FLT as a perfusion-independent imaging biomarker of tumour response in EGFR-mutated NSCLC patients undergoing treatment with an EGFR tyrosine kinase inhibitor

por Iqbal, R., Kramer, G. M., Frings, V., Smit, E. F., Hoekstra, O. S., Boellaard, R.
Publicado no EJNMMI Res (2018)

Prospective use of serial questionnaires to evaluate the therapeutic efficacy of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer

por Herder, G, van Tinteren, H, Comans, E, Hoekstra, O, Teule, G, Postmus, P, Joshi, U, Smit, E
Publicado em 2003

Prognostic value of the standardized uptake value for (18)F-fluorodeoxyglucose in patients with stage IIIB melanoma

por Bastiaannet, E., Hoekstra, O. S., de Jong, J. R., Brouwers, A. H., Suurmeijer, A. J. H., Hoekstra, H. J.
Publicado em 2012

Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metrics

por Cysouw, M. C. F., Golla, S. V. S., Frings, V., Smit, E. F., Hoekstra, O. S., Kramer, G. M., Boellaard, R.
Publicado no EJNMMI Res (2019)

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado em 2011

FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review

por Omloo, J. M. T., van Heijl, M., Hoekstra, O. S., van Berge Henegouwen, M. I., van Lanschot, J. J. B., Sloof, G. W.
Publicado em 2012

2-Deoxy-2[F-18]FDG-PET for Detection of Recurrent Laryngeal Carcinoma after Radiotherapy: Interobserver Variability in Reporting

por van der Putten, L., Hoekstra, O. S., de Bree, R., Kuik, D. J., Comans, E. F. I., Langendijk, J. A., Leemans, C. R.
Publicado em 2008

How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma

por Mijnhout, G S, Hoekstra, O S, van Lingen, A, van Diest, P J, Adèr, H J, Lammertsma, A A, Pijpers, R, Meijer, S, Teule, G J J
Publicado em 2003

Repeatability of quantitative (18)F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis

por Kramer, G. M., Liu, Y., de Langen, A. J., Jansma, E. P., Trigonis, I., Asselin, M.-C., Jackson, A., Kenny, L., Aboagye, E. O., Hoekstra, O. S., Boellaard, R.
Publicado no Eur J Nucl Med Mol Imaging (2018)

Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer

por Ankersmit, M., Hoekstra, O. S., van Lingen, A., Bloemena, E., Jacobs, M. A. J. M., Vugts, D. J., Bonjer, H. J., van Dongen, G. A. M. S., Meijerink, W. J. H. J.
Publicado no Eur J Nucl Med Mol Imaging (2019)

Practice, efficacy and cost of staging suspected non-small cell lung cancer: a retrospective study in two Dutch hospitals

por Herder, G, Verboom, P, Smit, E, van Velthoven, P C M, van den Bergh, J H A M, Colder, C, van Mansom, I, van Mourik, J C, Postmus, P, Teule, G, Hoekstra, O
Publicado em 2002

Radiomics analysis of pre-treatment [(18)F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment

por van Helden, E. J., Vacher, Y. J. L., van Wieringen, W. N., van Velden, F. H. P., Verheul, H. M. W., Hoekstra, O. S., Boellaard, R., Menke-van der Houven van Oordt, C. W.
Publicado no Eur J Nucl Med Mol Imaging (2018)

Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease

por Knaapen, P., de Haan, S., Hoekstra, O.S., Halbmeijer, R., Appelman, Y.E., Groothuis, J.G.J., Comans, E.F., Meijerink, M.R., Lammertsma, A.A., Lubberink, M., Götte, M.J.W., van Rossum, A.C.
Publicado em 2010

Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers

por Bruijnen, S. T. G., Verweij, N. J. F., Gent, Y. Y. J., Huisman, M. C., Windhorst, A. D., Kassiou, M., van de Ven, P. M., Lammertsma, A. A., Hoekstra, O. S., Voskuyl, A. E., van der Laken, C. J.
Publicado no PLoS One (2019)

Early lesion detection with (18)F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer

por Wondergem, M., Jansen, B. H. E., van der Zant, F. M., van der Sluis, T. M., Knol, R. J. J., van Kalmthout, L. W. M., Hoekstra, O. S., van Moorselaar, R. J. A., Oprea-Lager, D. E., Vis, A. N.
Publicado no Eur J Nucl Med Mol Imaging (2019)

Pelvic lymph-node staging with (18)F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -

por Jansen, B. H. E., Bodar, Y. J. L., Zwezerijnen, G. J. C., Meijer, D., van der Voorn, J. P., Nieuwenhuijzen, J. A., Wondergem, M., Roeleveld, T. A., Boellaard, R., Hoekstra, O. S., van Moorselaar, R. J. A., Oprea-Lager, D. E., Vis, A. N.
Publicado no Eur J Nucl Med Mol Imaging (2020)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis

por Goos, J A C M, Coupe, V M H, Diosdado, B, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Carvalho, B, van den Tol, M P, Verheul, H M W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado em 2013

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

por Goos, J A C M, Hiemstra, A C, Coupé, V M H, Diosdado, B, Kooijman, W, Delis-Van Diemen, P M, Karga, C, Beliën, J A M, Menke-van der Houven van Oordt, C W, Geldof, A A, Meijer, G A, Hoekstra, O S, Fijneman, R J A
Publicado em 2014

Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis

por Verburg, N., Hoefnagels, F.W.A., Barkhof, F., Boellaard, R., Goldman, S., Guo, J., Heimans, J.J., Hoekstra, O.S., Jain, R., Kinoshita, M., Pouwels, P.J.W., Price, S.J., Reijneveld, J.C., Stadlbauer, A., Vandertop, W.P., Wesseling, P., Zwinderman, A.H., De Witt Hamer, P.C.
Publicado no AJNR Am J Neuroradiol (2017)

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients

por Eertink, J. J., Burggraaff, C. N., Heymans, M. W., Dührsen, U., Hüttmann, A., Schmitz, C., Müller, S., Lugtenburg, P. J., Barrington, S. F., Mikhaeel, N. G., Carr, R., Czibor, S., Györke, T., Ceriani, L., Zucca, E., Hutchings, M., Kostakoglu, L., Loft, A., Fanti, S., Wiegers, S. E., Pieplenbosch, S., Boellaard, R., Hoekstra, O. S., Zijlstra, J. M., de Vet, H. C. W.
Publicado no Blood Adv (2021)